Marketdash

Baidu Soars 12% on Spinoff News as Markets See Wild Premarket Swings

MarketDash Editorial Team
3 hours ago
Baidu jumped over 12% in premarket trading after announcing plans to spin off its chip unit Kunlunxin on the Hong Kong Stock Exchange. Meanwhile, twenty stocks saw dramatic moves before the bell, with some biotechs swinging on FDA news and compliance issues.

Baidu Inc. (BIDU) had a pretty good morning, all things considered. The Chinese tech giant saw its shares leap 12.3% to $146.69 in premarket trading after announcing plans to spin off Kunlunxin (Beijing) Technology Co., Ltd. and list its H shares on the Main Board of the Hong Kong Stock Exchange. For those keeping score at home, Kunlunxin is Baidu's chip-making subsidiary, which makes this move part of the broader trend of tech companies separating their semiconductor operations to unlock value.

But Baidu wasn't the only stock making moves before the opening bell. Thursday's premarket session brought the usual mix of dramatic swings, ranging from biotechs dealing with FDA drama to companies announcing acquisitions and earnings beats. Let's walk through the biggest movers.

The Winners

Eason Technology Ltd (DXF) led the charge, surging 47.8% to $2.66 in premarket trading. This came after the stock dipped 10% on Wednesday, so someone clearly liked what they saw at those lower prices.

Aimei Health Technology Co Ltd (AFJK) wasn't far behind, gaining 32.8% to $85.01 in early trading. The stock had fallen 22% on Wednesday, making Thursday's bounce-back particularly noteworthy.

Biofrontera Inc (BFRI) climbed 28.5% to $0.73 after dropping more than 20% the previous day. The biotech company completed the transfer of FDA approvals for Ameluz and the RhodoLED Lamp Series last month, including both the New Drug Application and the Investigational New Drug application, which may be providing some delayed momentum.

ChowChow Cloud International HLDG Ltd (CHOW) rose 26.8% to $0.77 after delivering some genuinely impressive numbers. The company reported that first-half 2025 revenue jumped 81.3% year-over-year to $22.8 million, while net income climbed 80% to $1.6 million. That's the kind of growth that gets investors excited.

Rubico Inc (RUBI) gained 24.7% to $1.33 after announcing it entered into a purchase agreement to acquire a vessel-owning company from Top Ships. The acquisition includes a shipbuilding contract for a newbuilding mega yacht, which sounds like exactly the kind of specialized maritime asset that could appeal to a very specific buyer pool.

Sable Offshore Corp (SOC) added 21.4% to $10.96, extending Wednesday's 3% gain. Sometimes momentum just builds on itself.

Diginex Ltd (DGNX) rose 17.8% to $4.91 after declining 8% on Wednesday, marking another reversal from the previous session's losses.

Sellas Life Sciences Group Inc (SLS) gained 8.2% to $4.08, building on a strong 14% gain from Wednesday. When a biotech starts stringing together multiple days of gains, it's worth paying attention.

X T L Biopharmaceuticals Ltd (XTLB) rounded out the gainers with an 8.1% climb to $0.63, recovering from a more than 16% decline on Wednesday.

The Losers

On the flip side, Outlook Therapeutics Inc (OTLK) had a brutal morning, plunging 60.9% to $0.62. The biotech disclosed that the FDA issued a complete response letter for its ONS-5010/LYTENAVA biologics license application resubmission, indicating that the agency cannot approve the application in its present form for the treatment of wet age-related macular degeneration. A complete response letter is FDA-speak for "not yet," and it's rarely good news for a stock price.

Moolec Science SA (MLEC) fell 21.5% to $0.20 after receiving a determination letter from Nasdaq indicating that the company doesn't currently meet the minimum stockholders' equity requirement. Compliance issues are never fun, especially when they come with delisting risk.

Intelligent Bio Solutions Inc (INBS) dropped 19.2% to $7.70 after announcing a $10.0 million private placement priced at-the-market under Nasdaq rules. Dilution concerns likely drove the selloff, as investors calculated what the new shares would mean for their ownership stakes.

Nocera Inc (NCRA) declined 9.7% to $0.77 in premarket trading, though no specific catalyst was immediately apparent.

Nuvve Holding Corp (NVVE) dipped 9.3% to $2.30 despite announcing the closing of a private placement of Series A preferred stock and warrants. Sometimes even completed financings can weigh on a stock if investors worry about dilution or interpret the capital raise as a sign of cash burn concerns.

Net Lease Office Properties (NLOP) shares fell 8.9% to $23.50 in premarket trading without any clear news driving the decline.

Adlai Nortye Ltd (ANL) dropped 7.6% to $1.31, extending Wednesday's roughly 5% decline and suggesting continued pressure on the stock.

Semilux International Ltd (SELX) dipped 7.4% to $0.75, giving back some of Wednesday's 14% gain in a classic premarket reversal.

Progressive Corp (PGR) tumbled 5.8% to $214.60 in early trading. When a major insurer like Progressive moves significantly without obvious company-specific news, it's worth watching for broader sector developments.

Huachen AI Parking Mgmt Tech Hldg Co Ltd (HCAI) fell 5.3% to $0.33, reversing Wednesday's 8% gain and capping off a volatile two-day stretch.

The premarket session serves as a preview of the day's action, though with lower volume and wider spreads, these moves don't always stick once regular trading begins. But they do tell us what's on investors' minds as they digest overnight news and prepare for the opening bell.

Baidu Soars 12% on Spinoff News as Markets See Wild Premarket Swings

MarketDash Editorial Team
3 hours ago
Baidu jumped over 12% in premarket trading after announcing plans to spin off its chip unit Kunlunxin on the Hong Kong Stock Exchange. Meanwhile, twenty stocks saw dramatic moves before the bell, with some biotechs swinging on FDA news and compliance issues.

Baidu Inc. (BIDU) had a pretty good morning, all things considered. The Chinese tech giant saw its shares leap 12.3% to $146.69 in premarket trading after announcing plans to spin off Kunlunxin (Beijing) Technology Co., Ltd. and list its H shares on the Main Board of the Hong Kong Stock Exchange. For those keeping score at home, Kunlunxin is Baidu's chip-making subsidiary, which makes this move part of the broader trend of tech companies separating their semiconductor operations to unlock value.

But Baidu wasn't the only stock making moves before the opening bell. Thursday's premarket session brought the usual mix of dramatic swings, ranging from biotechs dealing with FDA drama to companies announcing acquisitions and earnings beats. Let's walk through the biggest movers.

The Winners

Eason Technology Ltd (DXF) led the charge, surging 47.8% to $2.66 in premarket trading. This came after the stock dipped 10% on Wednesday, so someone clearly liked what they saw at those lower prices.

Aimei Health Technology Co Ltd (AFJK) wasn't far behind, gaining 32.8% to $85.01 in early trading. The stock had fallen 22% on Wednesday, making Thursday's bounce-back particularly noteworthy.

Biofrontera Inc (BFRI) climbed 28.5% to $0.73 after dropping more than 20% the previous day. The biotech company completed the transfer of FDA approvals for Ameluz and the RhodoLED Lamp Series last month, including both the New Drug Application and the Investigational New Drug application, which may be providing some delayed momentum.

ChowChow Cloud International HLDG Ltd (CHOW) rose 26.8% to $0.77 after delivering some genuinely impressive numbers. The company reported that first-half 2025 revenue jumped 81.3% year-over-year to $22.8 million, while net income climbed 80% to $1.6 million. That's the kind of growth that gets investors excited.

Rubico Inc (RUBI) gained 24.7% to $1.33 after announcing it entered into a purchase agreement to acquire a vessel-owning company from Top Ships. The acquisition includes a shipbuilding contract for a newbuilding mega yacht, which sounds like exactly the kind of specialized maritime asset that could appeal to a very specific buyer pool.

Sable Offshore Corp (SOC) added 21.4% to $10.96, extending Wednesday's 3% gain. Sometimes momentum just builds on itself.

Diginex Ltd (DGNX) rose 17.8% to $4.91 after declining 8% on Wednesday, marking another reversal from the previous session's losses.

Sellas Life Sciences Group Inc (SLS) gained 8.2% to $4.08, building on a strong 14% gain from Wednesday. When a biotech starts stringing together multiple days of gains, it's worth paying attention.

X T L Biopharmaceuticals Ltd (XTLB) rounded out the gainers with an 8.1% climb to $0.63, recovering from a more than 16% decline on Wednesday.

The Losers

On the flip side, Outlook Therapeutics Inc (OTLK) had a brutal morning, plunging 60.9% to $0.62. The biotech disclosed that the FDA issued a complete response letter for its ONS-5010/LYTENAVA biologics license application resubmission, indicating that the agency cannot approve the application in its present form for the treatment of wet age-related macular degeneration. A complete response letter is FDA-speak for "not yet," and it's rarely good news for a stock price.

Moolec Science SA (MLEC) fell 21.5% to $0.20 after receiving a determination letter from Nasdaq indicating that the company doesn't currently meet the minimum stockholders' equity requirement. Compliance issues are never fun, especially when they come with delisting risk.

Intelligent Bio Solutions Inc (INBS) dropped 19.2% to $7.70 after announcing a $10.0 million private placement priced at-the-market under Nasdaq rules. Dilution concerns likely drove the selloff, as investors calculated what the new shares would mean for their ownership stakes.

Nocera Inc (NCRA) declined 9.7% to $0.77 in premarket trading, though no specific catalyst was immediately apparent.

Nuvve Holding Corp (NVVE) dipped 9.3% to $2.30 despite announcing the closing of a private placement of Series A preferred stock and warrants. Sometimes even completed financings can weigh on a stock if investors worry about dilution or interpret the capital raise as a sign of cash burn concerns.

Net Lease Office Properties (NLOP) shares fell 8.9% to $23.50 in premarket trading without any clear news driving the decline.

Adlai Nortye Ltd (ANL) dropped 7.6% to $1.31, extending Wednesday's roughly 5% decline and suggesting continued pressure on the stock.

Semilux International Ltd (SELX) dipped 7.4% to $0.75, giving back some of Wednesday's 14% gain in a classic premarket reversal.

Progressive Corp (PGR) tumbled 5.8% to $214.60 in early trading. When a major insurer like Progressive moves significantly without obvious company-specific news, it's worth watching for broader sector developments.

Huachen AI Parking Mgmt Tech Hldg Co Ltd (HCAI) fell 5.3% to $0.33, reversing Wednesday's 8% gain and capping off a volatile two-day stretch.

The premarket session serves as a preview of the day's action, though with lower volume and wider spreads, these moves don't always stick once regular trading begins. But they do tell us what's on investors' minds as they digest overnight news and prepare for the opening bell.